| ARTICLE |
|
|
|
|
|
| Year : 2000 | Volume
: 42
| Issue : 1 | Page : 101-103 |
Risperidone-Induced Neuroleptic Malignant Syndrome : A Case Report
G Venkatasubramanian1, BH Yogananda2, BN Gangadhar3
1 Junior Resident, Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore-560029, India
2 Senior Resident, Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore-560029, India
3 Additional Professor, Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore-560029, India
Correspondence Address:
B N Gangadhar
Additional Professor, Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore-560029
India
 Source of Support: None, Conflict of Interest: None  | Check |
PMID: 21407918 
A young male schizophrenic presented with neuroleptic malignant syndrome (NMS). Risperidone was the probable precipitating agent. Rigidity and elevated CPK levels poorly responded to bromocriptine, but showed good response to dantrolene. The role of specific treatment and the differential response of the symptom clusters are discussed.
[PDF]*
|
